NEW ENTERPRISE ASSOCIATES 16, L.P. - TREVI THERAPEUTICS, INC. 13D

Company

Trevi Therapeutics, Inc.

Filed

May 20, 2019

Accession Number

0001072613-19-000201

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →